Feb 09, 2021 / 06:00PM GMT
Operator
Good morning, and welcome to the Amyris Virtual Investor Mini-Series Part II. (Operator Instructions) Please note this event is being recorded. You may listen to a webcast replay of this call by going to the Investors section of Amyris' website. I would now like to turn the conference over to Han Kieftenbeld, Chief Financial Officer of Amyris. Please go ahead.
Hermanus Kieftenbeld - Amyris, Inc. - CFO
Thank you, operator, and good morning and good afternoon. With me today from Amyris are John Melo, President and Chief Executive Officer; Daya Fields, President, Pipette and Purecane; Catherine Gore, President, Biossance; Caroline Hadfield, Chief Executive Officer, Rose Inc., and President, Aprinnova; Sheila Shekar Pollak, Chief Marketing Officer of Biossance; and our guest, Julian Reis, Founder and Chief Executive Officer of SuperOrdinary. Today's webcast is the second session in the Amyris Virtual Investor Mini-Series after a very well-attended first session on December 15. The theme for the series is Delivering on the Promise of Synthetic Biology.
Today
Amyris Inc Second Virtual Investor Mini-Series Webinar Transcript
Feb 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers